ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly marketing, selling, and administrative ($M) ($M)
Annual figures from Eli Lilly's filings and investor materials
Latest, FY2025
11,094
Period ended Dec 31, 2025
Change on a year earlier
+29.1%
8,594 in FY2024
History
19 years
Since FY2007
Sources
13
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Marketing, selling, and administrative ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11,094 | +29.1% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 8,594 | +16.1% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 7,404 | +15.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2022 | Dec 31, 2022 | 6,440 | +0.1% | Form 10-K (filed 2023-02-22) ↗ |
| FY2021 | Dec 31, 2021 | 6,432 | +5.1% | Form 10-K (filed 2022-02-23) ↗ |
| FY2020 | Dec 31, 2020 | 6,121 | -1.5% | Form 10-K (filed 2021-02-17) ↗ |
| FY2019 | Dec 31, 2019 | 6,214 | +4.0% | Form 10-K (filed 2020-02-19) ↗ |
| FY2018 | Dec 31, 2018 | 5,975 | -0.1% | Form 10-K (filed 2020-02-19) ↗ |
| FY2017 | Dec 31, 2017 | 5,982 | -8.4% | Form 10-K (filed 2020-02-19) ↗ |
| FY2016 | Dec 31, 2016 | 6,528 | -0.1% | Form 10-K (filed 2019-02-19) ↗ |
| FY2015 | Dec 31, 2015 | 6,533 | -1.3% | Form 10-K (filed 2016-02-19) ↗ |
| FY2014 | Dec 31, 2014 | 6,621 | -7.1% | Form 10-K (filed 2015-02-19) ↗ |
| FY2013 | Dec 31, 2013 | 7,126 | -5.2% | Form 10-K (filed 2014-02-19) ↗ |
| FY2012 | Dec 31, 2012 | 7,514 | -4.6% | Form 10-K (filed 2013-02-21) ↗ |
| FY2011 | Dec 31, 2011 | 7,880 | +11.7% | Form 10-K (filed 2012-02-24) ↗ |
| FY2010 | Dec 31, 2010 | 7,053 | +2.3% | Form 10-K (filed 2011-02-22) ↗ |
| FY2009 | Dec 31, 2009 | 6,893 | +4.0% | Form 10-K (filed 2010-02-22) ↗ |
| FY2008 | Dec 31, 2008 | 6,626 | +8.7% | Form 10-K (filed 2010-02-22) ↗ |
| FY2007 | Dec 31, 2007 | 6,095 | – | Form 10-K (filed 2010-02-22) ↗ |
Cite this data
StockData. (2026). Eli Lilly Marketing, selling, and administrative ($M) ($M), annual FY2007–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/fin_sga
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.